Home / Nervous system / Zolmitriptan
ATC N02CC03 · Analgesics
Zolmitriptan shortage
As of 31 Oct 2026, Zolmitriptan has a reported shortage in 2 of the 5 countries we track (Austria, Belgium), covering 14 products.
Countries2/5
Products14packs or presentations
Short since3 May 20242.5 years ago
Earliest return15 Feb 2027company estimate
No return date6products
Main reasonManufacturing problem
Timeline
AustriaBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Zolmitriptan Sandoz 2,5 mg - Schmelztabletten, 2 Stück | Sandoz GmbH | 21 Aug 2024 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Zolmitriptan 1A Pharma 2,5 mg - Schmelztabletten, 6 Stück | 1 A Pharma GmbH | 23 Dec 2024 | not given | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
| AT | Zolmitriptan Sandoz 2,5 mg - Schmelztabletten, 6 Stück | Sandoz GmbH | 23 Jan 2025 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Zolmitriptan 1A Pharma 2,5 mg - Schmelztabletten, 2 Stück | 1 A Pharma GmbH | 19 Mar 2025 | not given | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
| AT | Zolmitriptan 1A Pharma 2,5 mg - Filmtabletten, 3 Stück | 1 A Pharma GmbH | 13 May 2025 | not given | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
| AT | Zolmitriptan 1A Pharma 2,5 mg - Filmtabletten, 6 Stück | 1 A Pharma GmbH | 13 May 2025 | not given | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
| BE | Zolmitriptan Sandoz 2.5 mg orodisp. tabl. 12 | Sandoz | 3 May 2024 | 15 Feb 2027 | Manufacturing problem Delay in production |
| BE | Zolmitriptan Sandoz 2.5 mg orodisp. tabl. 24 | Sandoz | 31 Oct 2024 | 15 Feb 2027 | Active ingredient shortage Active Substance not available |
| BE | Zolmitriptan ODIS Viatris 2.5 mg orodisp. tabl. 12 | Viatris GX | 19 May 2025 | 5 Aug 2027 | Manufacturing problem Delay in production |
| BE | Zolmitriptan ODIS Viatris 2.5 mg orodisp. tabl. 24 | Viatris GX | 4 Jul 2025 | 5 Aug 2027 | Other Other reason |
| BE | Zolmitriptan ODIS Viatris 2.5 mg orodisp. tabl. 48 | Viatris GX | 9 Jul 2025 | 5 Aug 2027 | Other Other reason |
| BE | Zolmitriptan ODIS Viatris 2.5 mg orodisp. tabl. 6 | Viatris GX | 21 Jul 2025 | 5 Aug 2027 | Other Other reason |
| BE | Zolmitriptan ODIS Viatris 5 mg orodisp. tabl. 12 | Viatris GX | 2 Jun 2026 | 5 Aug 2027 | Other Other reason |
| BE | Zolmitriptan ODIS Viatris 5 mg orodisp. tabl. 6 | Viatris GX | 20 Jul 2026 | 5 Aug 2027 | Manufacturing problem Delay in the release of the end product |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.